Stability indicating RP-HPLC method for the estimation of lacosamide in bulk and pharmaceutical dosage form
ABSTRACT:
chemically described as N2 -acetyl-N-benzyl-D-homoserinamide
used for the treatment of . It can also be prescribed off-label to treat
conditions such as diabetic neuropathic pain. It enhances slow inactivation of
voltage-gated sodium channels, resulting in stabilization of hyper excitable
neuronal repetitive neuronal firing. analytical methods [2-10] have been
reported for the estimation of , accurate and stability indicating
reversed-phase HPLC method lacosamide in pharmaceutical dosage form as per ICH
Figure 1: Chemical structure of lacosamide EXPERIMENTAL SECTION out on Waters
HPLC system (2695 module) equipped with module) with auto sampler and running
on Waters Empower software. The column used is Kromasil C Journal of Chemical
and Pharmaceutical Research, 2013, 5(11):732-739 ISSN : 0975-7384 CODEN(USA) :
JCPRC5 method for the estimation of lacosamide in and Ajaya Kumar Patnaik3
Vizianagaram, A.P, India ences, Berhampur, Orissa, India versity, Cuttack, Orissa,
India.
Further details to
visit: http://www.jocpr.com/
For more details
visit: http://www.jocpr.com/articles/stability-indicating-rphplc-method-for-the-estimation-of-lacosamide-in-bulk-and-pharmaceutical-dosage-form.pdf
Comments
Post a Comment